UPB1
From Wikipedia, the free encyclopedia
Ureidopropionase, beta
|
|||||||||||
Identifiers | |||||||||||
Symbol(s) | UPB1; BUP1 | ||||||||||
External IDs | OMIM: 606673 MGI: 2143535 HomoloGene: 9471 | ||||||||||
|
|||||||||||
RNA expression pattern | |||||||||||
Orthologs | |||||||||||
Human | Mouse | ||||||||||
Entrez | 51733 | 103149 | |||||||||
Ensembl | ENSG00000100024 | ENSMUSG00000033427 | |||||||||
Uniprot | Q9UBR1 | Q3UEK4 | |||||||||
Refseq | NM_016327 (mRNA) NP_057411 (protein) |
NM_133995 (mRNA) NP_598756 (protein) |
|||||||||
Location | Chr 22: 23.22 - 23.25 Mb | Chr 10: 74.85 - 74.88 Mb | |||||||||
Pubmed search | [1] | [2] |
Ureidopropionase, beta, also known as UPB1, is a human gene.[1]
This gene encodes a protein that belongs to the CN hydrolase family. Beta-ureidopropionase catalyzes the last step in the pyrimidine degradation pathway. The pyrimidine bases uracil and thymine are degraded via the consecutive action of dihydropyrimidine dehydrogenase (DHPDH), dihydropyrimidinase (DHP) and beta-ureidopropionase (UP) to beta-alanine and beta-aminoisobutyric acid, respectively. UP deficiencies are associated with N-carbamyl-beta-amino aciduria and may lead to abnormalities in neurological activity.[1]
[edit] References
[edit] Further reading
- Thomas HR, Ezzeldin HH, Guarcello V, et al. (2008). "Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism.". Pharmacogenet. Genomics 18 (1): 25-35. doi: . PMID 18216719.
- Thomas HR, Ezzeldin HH, Guarcello V, et al. (2008). "Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism.". Pharmacogenet. Genomics 17 (11): 973-87. doi: . PMID 18075467.
- van Kuilenburg AB, Meinsma R, Assman B, et al. (2007). "Genetic analysis of the first 4 patients with beta-ureidopropionase deficiency.". Nucleosides Nucleotides Nucleic Acids 25 (9-11): 1093-8. doi: . PMID 17065070.
- Collins JE, Wright CL, Edwards CA, et al. (2005). "A genome annotation-driven approach to cloning the human ORFeome.". Genome Biol. 5 (10): R84. doi: . PMID 15461802.
- van Kuilenburg AB, Meinsma R, Beke E, et al. (2006). "beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities.". Hum. Mol. Genet. 13 (22): 2793-801. doi: . PMID 15385443.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi: . PMID 14702039.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Sakamoto T, Sakata SF, Matsuda K, et al. (2002). "Expression and properties of human liver beta-ureidopropionase.". J. Nutr. Sci. Vitaminol. 47 (2): 132-8. PMID 11508704.
- Vreken P, van Kuilenburg AB, Hamajima N, et al. (1999). "cDNA cloning, genomic structure and chromosomal localization of the human BUP-1 gene encoding beta-ureidopropionase.". Biochim. Biophys. Acta 1447 (2-3): 251-7. PMID 10542323.
- Naguib FN, el Kouni MH, Cha S (1985). "Enzymes of uracil catabolism in normal and neoplastic human tissues.". Cancer Res. 45 (11 Pt 1): 5405-12. PMID 3931905.
|